Moreover, it seems that the risk of cancer significantly increases in patients displaying high anti-TIF1-γ autoantibody titers, specifically in patients with the IgG2 isotype, compared with their respective counterparts (46, 47). This evidence concerns the gene TRIM33 and cancer.